Efficacy/Safety Study to Explore a New Revised Topical Formulation in Atopic Dermatitis

NCT01948869 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

35

Enrollment

INDUSTRY

Sponsor class

Conditions

Dermatitis, Atopic

Interventions

DEVICE: Phoenix II (BAY81-2996)
DEVICE: Phoenix I (BAY81-2996)

Sponsor

Bayer